A retrospective study of the antibody response to Pasteurella haemolytica was conducted by using sera 
A retrospective study of the antibody response to Pasteurella haemolytica was conducted by using sera from 368 feedlot cattle divided among five experiments. In three experiments, live vaccines or a bacterin were administered to some of the cattle and others were left as nonvaccinated controls. In two experiments, cattle were not vaccinated. Clinical signs of disease with subsequent recovery developed in 48.0% of the cattle, and 10.3% of the cattle died. Vaccination had no apparent effect on morbidity or mortality. At the time of purchase, 78% of the cattle had low antibody titers (<25) as measured by a quantitative fluorometric immunoassay. In most groups of cattle (both vaccinated and nonvaccinated), there was a significant rise in mean antibody titers between the time of purchase and days 28 to 32 in the feedlot. The antibody titers at the time of shipment and days 28 to 32 and the ratio of the two antibody titers were compared with the health status of cattle. The antibody ratios were significantly greater for cattle that became sick and then recovered compared with those of cattle that remained healthy. Although significance could not be established, antibody titers at the time of shipment were higher for cattle that remained healthy compared with cattle that became sick and then recovered.
Bovine pneumonic pasteurellosis (shipping fever) is a severe fibrinous pneumonia of feedlot cattle (8) . Pasteurella haemolytica biotype A serotype 1 has been demonstrated to be an essential component in the etiology of shipping fever (3, 4) .
Studies of mechanisms of resistance to P. haemolytica in cattle have included serum antibody responses in cattle exposed to the organism under natural and experimental conditions (5, 6, (9) (10) (11) (12) (13) 15 body titers than those dying of other causes (10) . Experimental inoculation with bacterins or live bacteria have demonstrated rises in serum antibody titers to P. haemolytica (5, 6, 13, 14) . Correlative studies, however, between antibody titers to P. haemolytica after vaccination and health status have been limited to small groups of experimentally challenged cattle (6, 14) .
The data reported here are from a retrospective study of the antibody response to P. haemolytica as detected by a quantitative fluorometric immunoassay, using sera obtained from feedlot cattle that had been used in experimental vaccine or nutritional studies. (Table 3) .
Serology for nonvaccinated cattle. In each experiment, except experiment 3, there was a significant increase (P < 0.05) in mean antibody titers for nonvaccinated cattle between the time that they were initially sampled and day 28 to 32 in the feedlot (Table 4) . Antibody was not detected, however, in sera from 34 nonvaccinated cattle at the final sampling. Of these cattle, 29 were in experiment 3 . AB2 values of >100 were detected in 85 (37%) of 230 nonvaccinated cattle. Only 3 (6.8%) of 44 control animals in experiment 3 had AB2 values of >100. In experiment 4, nonvaccinated cattle had a significant rise in mean titer during the 10 days that they were comingled before shipment. During that time, signs of respiratory disease were seen in these cattle, but health status was not recorded for individual animals. Subsequently, in this experiment, mean antibody titer for the nonvaccinated group did not increase during the 30 days in the feedlot.
Serology for vaccinated cattle. Groups of vaccinated cattle had significant increase (P < 0.01) in mean antibody titers between the time of vaccination and the second serum sampling (Table 4). In experiments 3 and 4, antibody to P. haemolytica was not detected in 14 (30.4%) and 1 (2.7%) calves, respectively, 10 to 14 days after vaccination. At the final sampling, antibody to P. haemolytica was not detected in sera from nine (19.6%) vaccinated cattle in experiment 3 and one (2%) vaccinated steer in experiment 5. Serological response compared with health status. AB1, AB2, and the ratio of AB2 to AB1 were compared with health status (Table 5 ). There was a tendency (although statistically AB2 values and AB2/AB1 ratios were available for only four cattle that died because most of the cattle died before day 28. Those four cattle had individual AB2 values of 0, 42, 182, and 245. Antibody titers were also determined on sera obtained from cattle in experiment 1 on day 14. All cattle were alive at that time and mean titers were 7.9 ± 1.4, 5.1 ± 1.2, and 7.8 ± 1.6 for cattle that remained healthy, became sick and then recovered, and died, respectively. These differences were not significant (P > 0.05). (10) . In the present study, we were unable to corroborate these findings. From the data in Table 5 , it might appear that vaccinated cattle that died had substantially lower mean AB1 values than those of cattle that became sick and then recovered. However, of the 10 vaccinated cattle that died, 9 were in experiment 5. Because the vaccine in this experiment was administered at the time of shipment, AB1 values for these cattle could not be compared with those from experiments 3 and 4 in which cattle were vaccinated before shipment. We were also unable to establish any relationship between later antibody titers to P. haemolytica and death due to fibrinous pleuropneumonia.
In the present study, mean AB2/AB1 ratios were significantly greater in cattle that became sick and then survived compared with those that remained healthy. Therefore, a marked increase in antibody titer to P. haemolytica probably indicated that these animals became actively infected with P. haemolytica, responded to treatment, and recovered. This is not to imply that P. haemolytica was the only pathogenic agent involved in the observed illnesses in these experiments. In fact, in experiments 3 and 4 there were no changes in mean antibody titers for nonvaccinated cattle, implying that agents other than P. haemolytica may have been involved in the production of disease in these experiments.
In conclusion, the fluorometric immunoassay detected differences in serum antibody titers to P. haemolytica in cattle before and after vaccination and in many nonvaccinated cattle after 28 to 32 days in a feedlot. A rise in antibody titer to somatic antigens of P. haemolytica correlated with clinical signs of disease, suggesting that a natural challenge with the organism occurred in many cases. There is a need for controlled experimental studies to further determine whether there is a protective role for antibody to P. haemolytica in respiratory diseases of cattle.
